AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.

AstraZeneca shares declined while Bristol-Myers Squibb shares rose on Monday following reports of merger discussions between the two companies. Financial analysts have not identified clear strategic rationale for a combination between the two pharmaceutical manufacturers.

Next story